The synergistic interaction between FLT3-ITD and p53 haploinsufficiency or loss contributes to enhanced proliferation, impaired differentiation, and inhibited apoptosis, ultimately facilitating the development of leukemia [58]. The gene discussed is TP53; the disease is leukemia.